ANTENATAL PHENOBARBITAL IN THE PREVENTION OF NEONTAL INTRACRANIAL HEMORRHAGE

产前苯巴比妥预防新生儿颅内出血

• 批准号: 6246143
• 负责人: DAVID K STEVENSON
• 金额: $ 3.61万
• 依托单位: STANFORD UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-05-15 至 1997-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6246143
• 关键词: cerebral hemorrhage; cerebral ischemia /hypoxia; chemoprevention; clinical research; embryo /fetus chemotherapy; female; human pregnant subject; human subject; infant mortality; mother /infant health care; neuropsychology; pediatrics; perinatal; phenobarbital; premature infant human

Examines if Phenobarbital administered antenatally to pregnant women </= 32 wks gestation who are expected to deliver within 24 hours, will reduce the incidence of intracranial hemorrhage and/or ischemic brain injury, reduce the mortality rate and reduce the incidence of neurodevelopmental sequelae in the preterm neonate. The final phase of 18 month follow-up will be completed in early 1997.

检查孕妇是否在产前服用苯巴比妥</= 怀孕32周，预计24小时内分娩的人， 减少颅内出血和/或脑缺血的发生率 伤害，降低死亡率，减少发生率 早产儿神经发育后遗症。最后阶段 18个月的随访将于1997年初完成。